ASGCT 2026
Meet us at ASGCT 2026 booth 1049 and discover the right solutions for gene therapy from upstream production platforms and downstream solutions, to CDMO and contract testing services that will help you accelerate your manufacturing of viral-based therapies.
Immerse yourself in Booth 1049
- Experience the recently launched AAViator™ Production Platform, a comprehensive solution that streamlines AAV production, delivering consistently high titers and superior quality for gene therapy applications. Interested in a trial? Don’t miss the chance to consult with our experts!
- Discover unparalleled DNA clearance with Benzonase® Endonuclease Salt Tolerant and Benzonase® Endonuclease Safety Plus, designed to empower your DNA digestion. Be sure to catch the demo or request a sample!
- Learn how to maximize downstream purification efficiency using fit-for-purpose products from raw materials Deviron® Detergent to filtration solutions like Millistak+® HC and Pellicon® Capsule.
- Visit us to explore the new T7 RNA Polymerase Emprove® Expert and discover how to optimize your IVT reaction to advance your mRNA manufacturing.
Attend Our Talk:
Wednesday May 13th
11:15 – 11:45am
Location: Room 109AB
To 1000L and Beyond: Innovating AAV Manufacturing for the Next Wave of Gene Therapies
Presenter: Laura Juckem, Ph. D. - Vice President, Research & Development - Mirus Bio now part of MilliporeSigma
In the rapidly evolving cell and gene therapy landscape, manufacturing efficiency remains a critical bottleneck for advancing AAV therapeutics from clinical trials to commercial production. Current AAV manufacturing processes face three key challenges: speed to market, maximization of performance, and commercial viability. Innovation is required to enable successful commercialization of therapeutics to reach patients in need.
Many companies in the industry are moving towards platform approaches to streamline process development and GMP manufacturing. This session will explore:
- Best-in-class performance in AAV production
- Process scale-up and manufacturing feasibility
- Regulatory bottlenecks and solutions
Join this session to learn more about taking AAV production to new heights as the industry prepares for the next wave of gene therapies.
